TIMOLYNE SKINNER: Open Payments
NPI 1831300524 · HOLMDEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,678 in 103 payments from 18 companies in 2025. Trend: 2023 $2,147 · 2024 $1,863 · 2025 $1,678
Food & beverage: $1,678
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $496 |
| Lilly USA, LLC | 11 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $147 |
| GlaxoSmithKline, LLC. | 6 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Amgen Inc. | 5 | $82 |
| Dexcom, Inc. | 4 | $81 |
| ABBVIE INC. | 5 | $79 |
| Lundbeck LLC | 4 | $73 |
| SANOFI-AVENTIS U.S. LLC | 3 | $69 |
Products named: Wegovy, JARDIANCE, Ozempic, REXULTI, TRELEGY ELLIPTA, Kerendia, Dexcom G6 Transmitter, KISUNLA.
Industry payments across NJ — which companies pay providers there.
